Predicting chemotherapy-induced hematotoxicity elderly patients with metastatic breast cancer treated by pegylated liposomal doxorubicin (PLD): A population-based analysis on data coming from the DOGMES phase II GINECO study.

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. e19740-e19740 ◽  
Author(s):  
A. Sostelly ◽  
C. Falandry ◽  
E. Pujade-Lauraine ◽  
G. Freyer ◽  
M. Tod
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Elderly Patients ◽  
Phase Ii ◽  
Liposomal Doxorubicin ◽  
Metastatic Breast ◽  
Pegylated Liposomal Doxorubicin ◽  
Population Based

scholarly journals Pegylated liposomal doxorubicin plus carboplatin in patients with metastatic breast cancer: a phase II study

2012 ◽  
Vol 23 (10) ◽  
pp. 2599-2605 ◽  
Author(s):  
R.P. Collea ◽  
F.W. Kruter ◽  
J.E. Cantrell ◽  
T.K. George ◽  
S. Kruger ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Liposomal Doxorubicin ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Pegylated Liposomal Doxorubicin

Pegylated liposomal doxorubicin in elderly patients with metastatic breast cancer

2008 ◽  
Vol 8 (3) ◽  
pp. 331-342 ◽  
Author(s):  
Alessandro M Minisini ◽  
Claudia Andreetta ◽  
Gianpiero Fasola ◽  
Fabio Puglisi
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Elderly Patients ◽  
Liposomal Doxorubicin ◽  
Metastatic Breast ◽  
Pegylated Liposomal Doxorubicin
Sign in / Sign up

Export Citation Format

Share Document